274 related articles for article (PubMed ID: 37955252)
1. Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer's disease.
Zou D; Liu R; Lv Y; Guo J; Zhang C; Xie Y
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2270781. PubMed ID: 37955252
[TBL] [Abstract][Full Text] [Related]
2. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.
Kumar B; Dwivedi AR; Sarkar B; Gupta SK; Krishnamurthy S; Mantha AK; Parkash J; Kumar V
ACS Chem Neurosci; 2019 Jan; 10(1):252-265. PubMed ID: 30296051
[TBL] [Abstract][Full Text] [Related]
3. Repurposing of FDA-approved drugs as dual-acting MAO-B and AChE inhibitors against Alzheimer's disease: An in silico and in vitro study.
Mateev E; Kondeva-Burdina M; Georgieva M; Zlatkov A
J Mol Graph Model; 2023 Jul; 122():108471. PubMed ID: 37087882
[TBL] [Abstract][Full Text] [Related]
4. Coumarin-dithiocarbamate hybrids as novel multitarget AChE and MAO-B inhibitors against Alzheimer's disease: Design, synthesis and biological evaluation.
He Q; Liu J; Lan JS; Ding J; Sun Y; Fang Y; Jiang N; Yang Z; Sun L; Jin Y; Xie SS
Bioorg Chem; 2018 Dec; 81():512-528. PubMed ID: 30245233
[TBL] [Abstract][Full Text] [Related]
5. Dipropargyl substituted diphenylpyrimidines as dual inhibitors of monoamine oxidase and acetylcholinesterase.
Kumar B; Kumar V; Prashar V; Saini S; Dwivedi AR; Bajaj B; Mehta D; Parkash J; Kumar V
Eur J Med Chem; 2019 Sep; 177():221-234. PubMed ID: 31151057
[TBL] [Abstract][Full Text] [Related]
6. Morpholine-based chalcones as dual-acting monoamine oxidase-B and acetylcholinesterase inhibitors: synthesis and biochemical investigations.
Sasidharan R; Eom BH; Heo JH; Park JE; Abdelgawad MA; Musa A; Gambacorta N; Nicolotti O; Manju SL; Mathew B; Kim H
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):188-197. PubMed ID: 33430657
[TBL] [Abstract][Full Text] [Related]
7. First Synthesis of Racemic
Guieu B; Lecoutey C; Legay R; Davis A; Sopkova de Oliveira Santos J; Altomare CD; Catto M; Rochais C; Dallemagne P
Molecules; 2020 Dec; 26(1):. PubMed ID: 33375412
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer's disease.
Li F; Wang ZM; Wu JJ; Wang J; Xie SS; Lan JS; Xu W; Kong LY; Wang XB
J Enzyme Inhib Med Chem; 2016; 31(sup3):41-53. PubMed ID: 27384289
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, biological activity, molecular docking, and molecular dynamics of novel benzimidazole derivatives as potential AChE/MAO-B dual inhibitors.
Osmaniye D; Evren AE; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
Arch Pharm (Weinheim); 2022 Mar; 355(3):e2100450. PubMed ID: 34931332
[TBL] [Abstract][Full Text] [Related]
10. Identification of Butyrylcholinesterase and Monoamine Oxidase B Targeted Ligands and their Putative Application in Alzheimer's Treatment: A Computational Strategy.
Jabir NR; Rehman MT; Tabrez S; Alserihi RF; AlAjmi MF; Khan MS; Husain FM; Ahmed BA
Curr Pharm Des; 2021; 27(20):2425-2434. PubMed ID: 33634754
[TBL] [Abstract][Full Text] [Related]
11. Multitarget drug design strategy against Alzheimer's disease: Homoisoflavonoid Mannich base derivatives serve as acetylcholinesterase and monoamine oxidase B dual inhibitors with multifunctional properties.
Li Y; Qiang X; Luo L; Yang X; Xiao G; Zheng Y; Cao Z; Sang Z; Su F; Deng Y
Bioorg Med Chem; 2017 Jan; 25(2):714-726. PubMed ID: 27923535
[TBL] [Abstract][Full Text] [Related]
12. Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer's disease therapy.
Pachón-Angona I; Refouvelet B; Andrýs R; Martin H; Luzet V; Iriepa I; Moraleda I; Diez-Iriepa D; Oset-Gasque MJ; Marco-Contelles J; Musilek K; Ismaili L
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):479-489. PubMed ID: 30712420
[TBL] [Abstract][Full Text] [Related]
13. Sulfonyl thioureas with a benzo[d]thiazole ring as dual acetylcholinesterase/butyrylcholinesterase and human monoamine oxidase A and B inhibitors: An in vitro and in silico study.
Dinh Thanh N; Son Hai D; Ngoc Toan V; Thi Kim Van H; Thi Kim Giang N; Minh Tri N
Arch Pharm (Weinheim); 2024 May; 357(5):e2300557. PubMed ID: 38321839
[TBL] [Abstract][Full Text] [Related]
14. Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease.
Sterling J; Herzig Y; Goren T; Finkelstein N; Lerner D; Goldenberg W; Miskolczi I; Molnar S; Rantal F; Tamas T; Toth G; Zagyva A; Zekany A; Finberg J; Lavian G; Gross A; Friedman R; Razin M; Huang W; Krais B; Chorev M; Youdim MB; Weinstock M
J Med Chem; 2002 Nov; 45(24):5260-79. PubMed ID: 12431053
[TBL] [Abstract][Full Text] [Related]
15. Pyridoxine-resveratrol hybrids Mannich base derivatives as novel dual inhibitors of AChE and MAO-B with antioxidant and metal-chelating properties for the treatment of Alzheimer's disease.
Yang X; Qiang X; Li Y; Luo L; Xu R; Zheng Y; Cao Z; Tan Z; Deng Y
Bioorg Chem; 2017 Apr; 71():305-314. PubMed ID: 28267984
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 4-substituted benzyl-2-triazole-linked-tryptamine-paeonol derivatives and evaluation of their selective inhibitions against butyrylcholinesterase and monoamine oxidase-B.
Oh JM; Kang Y; Hwang JH; Park JH; Shin WH; Mun SK; Lee JU; Yee ST; Kim H
Int J Biol Macromol; 2022 Sep; 217():910-921. PubMed ID: 35908673
[TBL] [Abstract][Full Text] [Related]
17. Exploration of a Library of 3,4-(Methylenedioxy)aniline-Derived Semicarbazones as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase: Design, Synthesis, and Evaluation.
Tripathi RK; Rai GK; Ayyannan SR
ChemMedChem; 2016 Jun; 11(11):1145-60. PubMed ID: 27135466
[TBL] [Abstract][Full Text] [Related]
18. Mechanism-based pharmacokinetics-pharmacodynamics studies of harmine and harmaline on neurotransmitters regulatory effects in healthy rats: Challenge on monoamine oxidase and acetylcholinesterase inhibition.
Jiang B; Meng L; Zou N; Wang H; Li S; Huang L; Cheng X; Wang Z; Chen W; Wang C
Phytomedicine; 2019 Sep; 62():152967. PubMed ID: 31154274
[TBL] [Abstract][Full Text] [Related]
19. Selected 1,3-Benzodioxine-Containing Chalcones as Multipotent Oxidase and Acetylcholinesterase Inhibitors.
Jeong GS; Kaipakasseri S; Lee SR; Marraiki N; Batiha GE; Dev S; Palakkathondi A; Kavully FS; Gambacorta N; Nicolotti O; Mathew B; Kim H
ChemMedChem; 2020 Dec; 15(23):2257-2263. PubMed ID: 32924264
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of 4-arylcoumarins as potential anti-Alzheimer's disease agents.
Yun Y; Yang J; Miao Y; Wang X; Sun J
Bioorg Med Chem Lett; 2020 Feb; 30(4):126900. PubMed ID: 31882295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
